San Diego-based Viking Therapeutics marked by itself as a serious competitor inside the weight loss drug sector in February after revealing promising knowledge from the mid-stage trial of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when supplied to be a weekly injection As well as in March the com